Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer’s disease


BIBLIOGRAPHIC THERAPEUTIC AGENT ANIMAL MODEL EXPERIMENTAL DESIGN OUTCOMES

Bibliographic

Year of Publication:
2014
Contact PI Name:
Merce Pallas
Contact PI Affiliation:
Seccio de Farmacologia, Departament Farmacologia i Quımica, Terapeutica Facultat de Farmacia, Institut de Biomedicina, Universitat de Barcelona, Barcelona, Spain
Co-Authors:
David Porquet, Christian Grinan-Ferre, Isidre Ferrer, Antoni Camins, Coral Sanfeliu, Jaume del Valle
Primary Reference (PubMED ID):
Funding Source:
Spanish Ministry of Education and Science
Generalitat de Catalunya
Study Goal and Principal Findings:

This study investigated effects of resveratrol on neuroprotection, cognitive impairment, and neuropathology in APP/PS1 mice. Past studies have shown production of Aβ in AD Tg mice is reduced by the overexpression of Sirtuin 1 (SIRT1) and is increased by knocking out SIRT1 in the brain. Resveratrol, a naturally occurring polyphenol mainly found in grapes and red wine, has been reported as a caloric restriction (CR) mimetic with potential anti-aging properties. The most widely accepted mechanistic hypothesis is that resveratrol’s effects, in the same way as CR, are driven through SIRT1 regulation. Resveratrol also activates AMPK, which also regulates insulin sensitivity and mitochondrial biogenesis. This study showed long-term resveratrol treatment significantly prevented memory loss as measured by the object recognition test. Moreover, resveratrol reduced the amyloid burden and increased mitochondrial complex IV protein levels in mouse brain. These protective effects of resveratrol were mainly mediated by increased activation of SIRT1 and AMPK pathways in mice. However, an increase has been observed in IL1  and TNF gene expression, indicating that resveratrol promoted changes in inflammatory processes, although no changes were detected in other key actors of the oxidative stress pathway. Taken together, these findings suggest that resveratrol is able to reduce the harmful process that occurs in APP/PS1 mouse hippocampus, preventing memory loss.

Therapeutic Agent

Therapeutic Information:
Therapy Type:
Dietary Interventions & Supplements
Therapeutic Agent:
Resveratrol
Therapeutic Target:
Multi Target

Animal Model

Model Information:
Species:
Mouse
Model Type:
APPxPS1
Strain/Genetic Background:
Not Reported

Experimental Design

Is the following information reported in the study?:
Power/Sample Size Calculation
Randomized into Groups
Blinded for Treatment
Blinded for Outcome Measures
Pharmacokinetic Measures
Pharmacodynamic Measures
Toxicology Measures
ADME Measures
Biomarkers
Dose
Formulation
Route of Delivery
Duration of Treatment
Frequency of Administration
Age of Animal at the Beginning of Treatment
Age of Animal at the End of Treatment
Sex as a Biological Variable
Study Balanced for Sex as a Biological Variable
Number of Premature Deaths
Number of Excluded Animals
Statistical Plan
Genetic Background
Inclusion/Exclusion Criteria Included
Conflict of Interest

Outcomes

Outcome Measured
Outcome Parameters
Behavioral
Novel Object Recognition Test (NORT)
Histopathology
Dense-core/Compact Plaques
Biochemical
Sirtuin 1 (Sirt1)
p53
AMP-Activated Protein Kinase (AMPK)
phospho-AMP-Activated Protein Kinase (phospho-AMPK)
Mitochondrial Proteins
Catalase (CAT)
Superoxide Dismutase (SOD)
Synaptophysin
Presenilin 1 (PS1)
A Disintegrin and Metalloproteinase Domain 10 (ADAM10)
beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)
Amyloid Precursor Protein (APP)
APP-CTFs
Omics
Gene Expression Profile

Source URL: http://alzped.nia.nih.gov/neuroprotective-role-trans